Table 2.
Donor characteristics for kidneys recovered for transplantation from March 31, 2015 to September 30, 2019, by donor hepatitis C virus antibody and viremia status
| Donor Characteristics | Aviremic Seropositive, n=1984 | Viremic, n=3640 | Aviremic Seropositive, n=76,466 | Total, n=82,090 | ||||
|---|---|---|---|---|---|---|---|---|
| n | % | N | % | n | % | n | % | |
| Age, yr | ||||||||
| <18 | 6 | 0.30 | 8 | 0.22 | 7522 | 10 | 7536 | 9 |
| 18–30 | 470 | 24 | 1293 | 36 | 17,978 | 24 | 19,741 | 24 |
| 31–44 | 737 | 37 | 1537 | 42 | 18,082 | 24 | 20,356 | 25 |
| 45–59 | 619 | 31 | 699 | 19 | 23,663 | 31 | 24,981 | 30 |
| ≥60 | 152 | 8 | 103 | 3 | 9221 | 12 | 9476 | 12 |
| Sex | ||||||||
| Female | 937 | 47 | 1282 | 35 | 30,118 | 39 | 32,337 | 39 |
| Male | 1047 | 53 | 2358 | 65 | 46,348 | 61 | 49,753 | 61 |
| Race | ||||||||
| White | 1675 | 84 | 3001 | 82 | 50,473 | 66 | 55,149 | 67 |
| Black | 108 | 5 | 239 | 7 | 11,576 | 15 | 11,923 | 15 |
| Hispanic | 161 | 8 | 320 | 9 | 10,916 | 14 | 11,397 | 14 |
| Other | 40 | 2 | 80 | 2 | 3501 | 5 | 3621 | 4 |
| Body mass index, kg/m2 | ||||||||
| <18.5 | 46 | 2 | 77 | 2 | 4584 | 6 | 4707 | 6 |
| 18.5–24.9 | 589 | 30 | 1495 | 41 | 24,119 | 32 | 26,203 | 32 |
| 25–29.9 | 680 | 34 | 1276 | 35 | 22,837 | 30 | 24,793 | 30 |
| 30–34.9 | 395 | 20 | 507 | 14 | 13,711 | 18 | 14,613 | 18 |
| ≥35 | 274 | 14 | 285 | 8 | 11,215 | 15 | 11,774 | 14 |
| Diabetes status | ||||||||
| No | 1804 | 91 | 3501 | 96 | 68,706 | 90 | 74,011 | 90 |
| Yes | 180 | 9 | 139 | 4 | 7760 | 10 | 8079 | 10 |
| Hypertension status | ||||||||
| No | 1361 | 69 | 3021 | 83 | 51,484 | 67 | 55,866 | 68 |
| Yes | 623 | 31 | 619 | 17 | 24,982 | 33 | 26,224 | 32 |
| Kidney donor profile index (%) | ||||||||
| <25 | 14 | 0.71 | 53 | 1 | 17,363 | 23 | 17,430 | 21 |
| 25–49 | 222 | 11 | 634 | 17 | 12,164 | 16 | 13,020 | 16 |
| 50–84 | 1271 | 64 | 2569 | 71 | 35,652 | 47 | 39,492 | 48 |
| ≥85 | 477 | 24 | 384 | 11 | 11,287 | 15 | 12,148 | 15 |
| Donation after cardiac death | ||||||||
| No | 1676 | 84 | 3087 | 85 | 61,032 | 80 | 65,795 | 80 |
| Yes | 308 | 16 | 553 | 15 | 15,434 | 20 | 16,295 | 20 |
| Cause of death | ||||||||
| Anoxia | 1344 | 68 | 2504 | 69 | 31,122 | 41 | 34,970 | 43 |
| Cerebrovascular/stroke | 324 | 16 | 465 | 13 | 21,226 | 28 | 22,015 | 27 |
| Head trauma | 314 | 16 | 665 | 18 | 23,821 | 31 | 24,800 | 30 |
| CNS tumor | 2 | 0.10 | 6 | 0.16 | 297 | 0.39 | 305 | 0.37 |
| Discard | ||||||||
| No | 1360 | 69 | 2322 | 64 | 62,519 | 82 | 66,201 | 81 |
| Yes | 624 | 31 | 1318 | 36 | 13,947 | 18 | 15,889 | 19 |
| Per PHS, does the donor have risk factors for blood-borne disease transmission? | ||||||||
| No | 606 | 31 | 646 | 18 | 61,217 | 80 | 62,469 | 76 |
| Yes | 1378 | 69 | 2994 | 82 | 15,249 | 20 | 19,621 | 24 |
| Biopsy status | ||||||||
| No | 746 | 38 | 1642 | 45 | 36,233 | 47 | 38,621 | 47 |
| Yes | 1238 | 62 | 1998 | 55 | 40,233 | 53 | 43,469 | 53 |
| Glomerulosclerosis | ||||||||
| 0–5 | 794 | 40 | 1471 | 40 | 24,478 | 32 | 26,743 | 33 |
| 6–10 | 198 | 10 | 255 | 7 | 6339 | 8 | 6792 | 8 |
| 11–15 | 69 | 3 | 94 | 3 | 3039 | 4 | 3202 | 4 |
| 16–20 | 51 | 3 | 64 | 2 | 1921 | 3 | 2036 | 2 |
| ≥20 | 119 | 6 | 108 | 3 | 4322 | 6 | 4549 | 6 |
| Indeterminate | 10 | 0.50 | 9 | 0.25 | 225 | 0.29 | 244 | 0.30 |
| Unknown | 743 | 37 | 1639 | 45 | 36,142 | 47 | 38,524 | 47 |
Aviremic, donor nucleic acid amplification test negative; viremic, donor nucleic acid amplification test positive; CNS, central nervous system; PHS, public health service.